2de JONGH FE, JANSSEN HL, de MAN RA, et al. Survival and prognostic indicators in hepatitis B surface antigen -posi- tive cirrhosis of the liver [ J ]. Gastroenterology, 1992,103 (5): 1630 -1635.
3HOSAKA T, SUZUKI F, KOBAYASHI M, et al. Long-term entecavir treatment reduces hepatocellular carcinoma inci- dence in patients with hepatitis B virus infection [ J ]. Hepa- tology, 2013, 58(1 ): 98 -107.
4European Association for the Study of the Liver. EASL clinical practice guidelines, management of chronic hepatitis B [ J ]. J Hepatol, 2009, 50(2) : 227 -242.
5LI N, LAI EC, SHI J, et al. A comparative study of antiviral therapy after resection of hepatoellular carcinoma in the im- mune-active phase of hepatitis B virus infection [ J]. Ann Surg Oncol, 2012, 17(1 ): 179 -185.
6HUANG L, LI J, LAU WY, et al. Perioperative reactivation of hepatitis B virus replication in patients undergoing partial hep- atectomy for hepatocellular carcinoma [ J ]. J Gastroenterol Hepatol, 2012, 27(1). 158-164.
7Youssef NF,Shepherd A,Evans JM,Wyke S.Translating and testing the Liver Disease Symptom Index 2.0 for administration to people with liver cirrhosis in Egypt.Int J Nurs Pract 2012; 18: 406-416.
8Taniguchi E,Kawaguchi T,Otsuka M,Uchida Y,Nagamatsu A,Itou M,Oriishi T,Ishii K,Imanaga M,Suetsugu T,Otsuyama J,Ibi R,Ono M,Tanaka S,Sata M.Nutritional assessments for ordinary medical care in patients with chronic liver disease.Hepatol Res 2013; 43: 192-199.
9Tsai LH,Lin CM,Chiang SC,Chen CL,Lan SJ,See LC.Symptoms and distress among patients with liver cirrhosis but without hepatocellular carcinoma in Taiwan.Gastroenterol Nurs 2014; 37: 49-59.
10Wu LJ,Wu MS,Lien GS,Chen FC,Tsai JC.Fatigue and physical activity levels in patients with liver cirrhosis.J Clin Nurs 2012; 21: 129-138.
